Skip to main content
CML-CP: Bosutinib outscores imatinib as a frontline treatment option in Asian subpopulation
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
CML-CP: Bosutinib outscores imatinib as a frontline treatment option in Asian subpopulation
User login
Username
Password
Reset your password
concept
Lead
score
Chronic Myelogenous Leukemia
1
1
Specialty
Lead
score
Hematology-Oncology
1
1